Guidance producer subject to accreditation: National Patient Safety Agency (NPSA) for the Rapid Response Reports
|
|
- Dortha Lang
- 5 years ago
- Views:
Transcription
1 Guidance producer subject to accreditation: National Patient Safety Agency (NPSA) for the Rapid Response Reports Date: 6 May 2010 Draft Accreditation Report for consultation Page 1 of 19
2 Contents Introduction... 3 Accreditation recommendation... 3 Implementation... 5 Reapplication for accreditation... 5 Appendix A: NHS Evidence accreditation analysis... 7 Appendix B: Bibliography Appendix C: Advisory Committee members, external advisers and NHS Evidence accreditation team Page 2 of 19
3 Introduction The NHS Evidence Accreditation Scheme recognises organisations that demonstrate high standards in producing health or social care guidance. Evidence users can therefore have high confidence in the quality of the information. Organisations can publicly display a seal of approval called an Accreditation Mark for three years after their processes have been accredited. The process for accrediting producers of guidance and recommendations for practice is described in the process manual 1. Accreditation recommendation It is proposed that the process to produce Rapid Response Reports (RRR) guidance by the National Patient Safety Agency (NPSA) is recommended for NHS Evidence accreditation. This draft decision is subject to public consultation before a final decision is made. Background to the guidance producer The National Patient Safety Agency is an Arm s Length Body of the Department of Health (DH). The National Reporting and Learning Service (NRLS) is a division of the NPSA that aims improve patient safety by identifying and reducing risks to patients receiving NHS care. The NRLS analyses patient safety incidents received via its national reporting system. Clinicians and safety experts help analyse information in the reporting system to identify common risks and opportunities to improve patient safety. Issues are then communicated by distributing Rapid Response Reports (RRRs). The objective of Rapid Response Reports is to alert health professionals to newly identified and important risks of medicines and devices, and provide advice on how these risks can be minimised. The safety alerts are provided to healthcare professionals to guide C232A0-19B9-E0B5-D4A11FA899F4C219 Page 3 of 19
4 decisions about the safety of drugs and devices, which are aimed at improve individual and population health. Summary The Advisory Committee considered that the process for the production of Rapid Response Reports from the National Patient Safety Agency demonstrates compliance with 23 of the 24 applicable criteria for accreditation. The process for the development of Rapid Response Reports is described in the policy documents, provided in Appendix B which were last updated in July This documentation underpinning the guidance producer s processes is robust, comprehensive and fit for purpose. The National Patient Safety Agency involves a wide range of stakeholders, and minimises bias through a combination of guidance decisions determined by multidisciplinary groups, peer review and transparency in the way the work is funded. Recommendations are clear, specific and unambiguous, and the guidance is distributed widely. Suggestions to further strengthen National Patient Safety Agency processes for developing the Rapid Response Reports include: The dates of search used in the search strategy should be clearly stated within the Rapid Response Reports or the associated documentation. A regular updating policy for the process manual should be produced and adhered to. This draft decision is now going out for public consultation, and the decision will be reviewed by the committee in the light of any feedback received before making a final recommendation. David Haslam Chair, Advisory Committee May 2010 Page 4 of 19
5 Implementation If accreditation is awarded, guidance from the accredited producer will be identified on NHS Evidence by the Accreditation Mark. The accredited guidance producer is also granted a royalty-free, worldwide licence to use the NHS Evidence Accreditation Mark in accordance with the Conditions and Terms of Use 2. Providing these conditions are met, a guidance producer's accreditation will last for three years from publication of approval on the NHS Evidence website. Accredited guidance producers must take reasonable steps to ensure the accredited processes are followed when generating the type of evidence for which they are accredited. Accredited guidance producers should have quality assurance mechanisms in place and must inform NHS Evidence of any significant change to a process within 30 days. Figure: The NHS Evidence Accreditation Mark 2 D471CA81220F57DA Page 5 of 19
6 Reapplication for accreditation If accreditation is not granted, guidance from the non-accredited producer will still be available on the NHS Evidence site but will not be identified by the accreditation mark graphic. Guidance producers that are not accredited following the accreditation process have the opportunity to reapply from one year after the previous assessment. It is assumed that the organisation will have addressed any concerns highlighted in the original assessment before reapplying. The NHS Evidence team will provide detailed feedback and advice on areas where improvement is required to meet the criteria in a future application. Page 6 of 19
7 Appendix A: NHS Evidence accreditation analysis The Advisory Committee considered the following analysis of the guidance producer s compliance with NHS Evidence accreditation criteria, which covers six discrete domains. The full analysis leading to the accreditation decision is shown below. Domain Criterion Evidence for meeting the criterion Accreditation decision Does the guidance producer have a policy in place and adhered to that requires them to explicitly detail: Scope and purpose 1.1 Overall objective The overall objective is clearly defined and implemented in the Rapid Response Reports 1 3 as described in the policy documents The description of the safety issue in the Rapid Response Reports 1 3 indicates the overall objective. 1.2 The clinical, healthcare or social questions covered The clinical questions are the safety issues for each Rapid Response Report 1 3, which meets the overall aim given by the guidance producer in response to criterion 1.1, as described in the policy documents Page 7 of 19
8 Domain Criterion Evidence for meeting the criterion Accreditation decision 1.3 Population and/or target audience to whom the guidance applies The Scale of patient safety issue section of the Template for Formal Scoping Report 7 indicates that the staff and patients to whom the guidance applies should be described. In addition section 2 of the Template for literature review 8 is entitled Intended audience. In three pieces of guidance reviewed as evidence the target audience and patient populations are indicated within both the Rapid Response Reports 1 3 and the supporting information. 1.4 Guidance includes clear recommendations in reference to specific clinical, healthcare or social circumstances The recommendations are clearly linked to specific safety circumstances as described in the policy documents The Rapid Response Reports 1 3 are single page, one topic safety guidance and so the recommendations are clearly linked to the specific circumstances described in the guidance. Does the guidance producer have a policy in place and adhered to that means it includes: Stakeholder involvement 2.1 Individuals from all relevant stakeholder groups, including patient groups, in developing guidance 2.2 Patient and service user representatives and seeks patients views and preferences in developing guidance The production of the Rapid Response Reports 1 3 includes individuals from relevant stakeholder groups as described in the policy documents The production of the Rapid Response Reports 1 3 includes patient s views. The NPSA core stakeholder list 9 includes some generic patient groups. It would also include content-specific patient groups for instance, renal patients for haemodialysis Rapid Response Reports. Page 8 of 19
9 Domain Criterion Evidence for meeting the criterion Accreditation decision 2.3 Representative intended users in developing guidance. Intended users are involved in the development of the Rapid Response Reports 1 3 described in the policy documents Does the guidance producer have a clear policy in place that: 3.1 Requires the guidance producer to use systematic methods to search for evidence and provide details of the search strategy Systematic methods were used to search for evidence on which the Rapid Response Reports 1 3 are based and the search strategy detailed as described in the policy documents 4 12, specifically the Template for literature review 8 which outlines the processes to be followed for the search strategy. Rigour of development 3.2 Requires the guidance producers to state the criteria and reasons for inclusion or exclusion of evidence identified by the evidence review The inclusion and exclusion criteria are defined in the production of the Rapid Response Reports 1 3 as described in the policy documents 1-9. The Template for literature review 8 section 5.0 states Detail search strategy used, including databases, whether grey literature or internet were searched, and any exclusions, e.g. country, language, dates. 3.3 Describes the strengths and limitations of the body of evidence and acknowledges any areas of uncertainty The strength and limitations of the evidence are defined in the production of the Rapid Response Reports 1 3 as described in the policy documents The Template for literature review 8 evidence tables show Limitations in the comments section of the template and the guidance producer further described this process in its application. Page 9 of 19
10 Domain Criterion Evidence for meeting the criterion Accreditation decision 3.4 Describes the method used to arrive at recommendations (for example, a voting system or formal consensus techniques like Delphi consensus) 3.5 Requires the guidance producers to consider the health benefits against the side effects and risks in formulating recommendations The method used to arrive at recommendations in the Rapid Response Reports 1 3 are explained as described in the policy documents The information supplied by the guidance producer can be found in Sample minutes from weekly response meeting 11. The risks versus health benefits are considered in the production of the Rapid Response Reports 1 3 as described in the policy documents The principle aim of these guidance products is to balance health benefits against risks by providing healthcare professionals with up to date safety information to better equip health professionals to make choices and therefore make patients safe. 3.6 Describes the processes of external peer review The peer review process used in the production of the Rapid Response Reports 1 3 is clearly defined as described in the policy documents A typical consultation will involve over fifty individuals and organisations. 3.7 Describes the process of updating guidance and maintaining and improving guidance quality The process of updating and maintaining guidance quality is observed in the Rapid Response Reports 1 3 as described in the policy documents 1-9. Rapid Response Reports 1 3 have a shelf life of six months, appoint a content lead to respond to queries, post statements of clarification on common queries and noted that the guidance refers to regular reviews. Page 10 of 19
11 Domain Criterion Evidence for meeting the criterion Accreditation decision Does the guidance producer ensure that: 4.1 Recommendations are specific, unambiguous and clearly identifiable The Rapid Response Reports 1 3 are single page safety notices which address one safety issue. Therefore all recommendations in the Rapid Response Reports 1 3 are specific, unambiguous and clearly identifiable as Clarity and described in the policy documents presentation 4.2 Different options for the management of the condition or options for intervention are clearly presented Rapid Response Reports 1 3 guidance is related to the safety of medicines and devices rather than the management of a condition. Recommendations are specific to the safety issues for a medicine or a device. There is no information supplied about treating specific conditions Not applicable and therefore this criterion is considered as not applicable. Page 11 of 19
12 Domain Criterion Evidence for meeting the criterion Accreditation decision 4.3 The date of search, the date of publication or last update and the proposed date for review are clearly stated 4.4 The content of the guidance is suitable for the specified target audience. If patients or service users are part of this audience, the language should be appropriate. The date of publication is clearly stated on the example Rapid Response Reports 1 3 reviewed as evidence. Due to the type of guidance product the review part of the criterion is considered as not applicable. Since the subject of the guidance is updates of drug and device safety driven by new evidence, the guidance is event rather than date led. In this case the proposed date for review does not exist, as stated by the guidance producer. No dates of search are shown in the example Rapid Response Reports 1 3 and the supporting information reviewed as evidence. The Template for literature review 8 section 5 shows that dates should be used for searching, but evidence of dates could not be found in guidance examples. The content of the Rapid Response Reports 1 3 is suitable for its target audience as described in the policy documents The Rapid Response Reports are produced for clinical and service staff as specified by the guidance producer in its response to criterion 2.1 and therefore the content is suitable. Not fully met Page 12 of 19
13 Domain Criterion Evidence for meeting the criterion Accreditation decision Does the guidance producer routinely consider: 5.1 Publishing support tools to aid implementation of guidance Support tools are published to aid implementation of the Rapid Response Reports 1 3 by the National Patient Safety Agency. Applicability 5.2 Discussion of potential organisational and financial barriers in applying its recommendations The organisational and financial barriers to implementing the recommendations in the Rapid Response Reports 1 3 are assumed to be overridden by the imperative of the safety issues identified. In addition the guidance producer stated that implementation considerations are raised with the Department of Health (DH). 5.3 That their guidance is current, with review criteria for monitoring and/or audit purposes within each product. The Rapid Response Reports 1 3 are current and audit of the uptake and use of this guideline is undertaken. The guidance producer provided examples of how it audits the implementation of guidance in association with other professional bodies. Does the guidance producer: Editorial independence 6.1 Ensure editorial independence from the funding body The Rapid Response Reports 1 3 are editorially independent from the funding body. The NPSA is part of the NHS. All funding for the guideline programmes is from the DH and Welsh Assembly. In addition the guidance is developed via a wide number of individual and professional groups. Page 13 of 19
14 Domain Criterion Evidence for meeting the criterion Accreditation decision 6.2 Demonstrate transparency about the funding mechanisms for its guidance 6.3 Record and state any potential conflicts of interest of individuals involved in developing the recommendations The guidance producer stated that Rapid Response Reports 1 3 are produced as part of NPSA core business. The guidance producer s website shows the annual accounts and breakdown of the funds. In the original submission no conflicts of interest policy could be found. As part of the guidance producer feedback the conflicts of interest policy was produced and implemented and evidence of this policy in practice was supplied. 6.4 Take account of any potential for bias in the conclusions or recommendations of the guidance The Rapid Response Reports 1 3 production minimises bias via a combination of guidance decisions determined by multidisciplinary groups, peer review and transparency in the way the work is funded, ensuring this criterion is satisfied as described in the policy documents Oxygen safety in hospitals, RRR ref 1124; 2 Mitigating surgical risk in patients undergoing hip arthroplasty for fractures of the proximal femur RRR ref 0958; 3 Reducing risk of overdose with midazolam injection in adults pathway RRR ref 1074; 4 Response unit overview ; 5 Incident Screening Summary; 6 Terms of Reference - Weekly Response Group; 7 Template for Formal Scoping Report; 8 Template for literature review; 9 List of stakeholders; 10 Template - RRR Invitation to comment letter; 11 Sample minutes from weekly response meeting; 12 Checklist for RRR development and approval Page 14 of 19
15 Appendix B: Bibliography Appendix B lists the additional information taken into account in the analysis and considered by the Committee. Document name Description Location A list of issued RRRs Submission document Annex A Issued RRRs Response unit overview Policy document Annex B Overview Incident Screening Summary Policy document Annex C Incident Screening Summary Terms of Reference - Weekly Response Group Policy document Annex D Terms of Reference - Weekly Response Group Template for Formal Scoping Report Policy document Annex E Template for Formal Scoping Report Template for literature review Policy document Annex F Template for literature review List of stakeholders Submission document Annex G List of stakeholders Template - RRR Invitation to comment letter Policy document Annex H Template - RRR Invitation to comment letter Sample minutes from weekly response meeting Submission document Annex I Sample minutes from weekly response meeting Checklist for RRR development and approval Policy document Annex J Checklist for RRR development and approval Oxygen safety in hospitals (Ref 1124) RRR guidance used as evidence ces/type/alerts/?entryid45=62811 Mitigating surgical risk in patients undergoing hip RRR guidance used as evidence ces/type/alerts/?entryid45=59867 arthroplasty for fractures of the proximal femur (Ref 0958) Reducing risk of overdose with midazolam injection in adults pathway (Ref 1074) RRR guidance used as evidence ces/type/alerts/?entryid45=59896 Page 15 of 19
16 Appendix C: Advisory Committee members, external advisers and NHS Evidence accreditation team NHS Evidence Advisory Committee Members The NHS Evidence Advisory Committee operates as a standing advisory committee of the Board of the National Institute for Health and Clinical Excellence (NICE). The Committee provides advice to the Institute on a framework for accrediting sources of evidence that should be recognised as trusted sources of information for the NHS. The Chair of the Committee is appointed by the Institute s Board and the meetings are conducted by the Chair or in his/her absence the vice chair. The current Chair is David Haslam. A full list of the Advisory Committee membership is available on the NICE website 3. The members have been appointed for a period of 18 months. This may be extended by mutual agreement to a further term of 3 years and up to a maximum term of office of 10 years. The decisions of the Committee are arrived at by a consensus of those members present. The quorum is set at 50% of committee membership. The Committee submits its recommendations to the Institute s Guidance executive which acts under delegated powers of the Institute s Board in considering and approving its recommendations. Committee members are asked to declare any interests in the guidance producer to be accredited. If it is considered that there is a conflict of interest, the member(s) is excluded from participating further in the discussions. A list of the committee members who took part in the discussions for this accreditation decision appears below. 3 Page 16 of 19
17 Title Name Surname Role Organisation Ms Judy Birch Lay member Ms Parul Desai Director of Population Health NHS Information Centre Professor David Haslam National Clinical Advisor Care Quality Commission Dr Bobbie Jacobson Dr Monica Lakhanpaul Director of London Health Observatory, Vice Chair of Association of PH Observatories Senior Lecturer / Consultant Paediatrician / Clinical Director London Health Observatory Health Education Research and Development Unit (HERADU), Department of Medical Education and Social Care, University of Leicester Mr John Lee President The Royal College of Ophthalmologists Ms Ruth Liley Professor Jon Nicholl Professor Sandy Oliver Assistant Director of Quality Improvement Professor of Health Services Research Professor of Public Policy, Deputy Director, Social Science Research Unit Marie Curie Cancer Care School of Health and Related Research (ScHARR) University of Sheffield Cochrane Consumers and Communication Review Group, University of London Dr Carl Parker PEC Chair Stockton-on-Tees Teaching PCT Mr Adrian Reyes- Hughes Associate Clinical Director NHS Direct Dr Karen Ritchie Ms Sasha Shepperd Lead Health Services Researcher Senior Research Scientist, Department of Public Health NHS Quality Improvement Scotland University of Oxford Professor Stephen Singleton Medical Director / Regional North East Strategic Health Page 17 of 19
18 Director of Public Health Dr Peter Smith Vice President Authority National Association of Primary Care Dr Mark Strong Ms Gill Swash MRC Fellow, Section of Public Health Head of knowledge and Library Services School of Health and Related Research (ScHARR) University of Sheffield NHS Western Cheshire Dr Sara Twaddle Director Scottish Intercollegiate Guidelines Network Advisory Committee Deputies Title Name Surname Role Organisation National Director for NHS Alliance Mrs Julie Wood Practice Based commissioning function Commissioning Deputising for Brian Fisher Ms Diane Gwynne Smith Head of Knowledge Management Social Care Institute for Excellence (SCIE) Amanda Edwards External Advisers for the National Patient Safety Agency (NPSA) Rapid Response Reports guidance accreditation application Vicki Wilkinson, Network Manager, Primary Care Research Network North West, Halton & St Helens PCT, UK Tracy NDiaye, Directorate Manager of Research, Clinical Research Facility Sheffield Children's NHS Foundation Trust, UK Page 18 of 19
19 NHS Evidence accreditation team for the National Patient Safety Agency (NPSA) Rapid Response Reports guidance accreditation application Stephanie Birtles, Accreditation Technical Analyst, NHS Evidence, National Institute for Health and Clinical Excellence, Manchester, UK Dr Paul Chrisp, Associate Director Accreditation, NHS Evidence, National Institute for Health and Clinical Excellence, Manchester, UK Page 19 of 19
Medicines and Healthcare products Regulatory Agency (MHRA) Guidance producer subject to accreditation. Process subject to accreditation
Guidance producer subject to accreditation Process subject to accreditation Medicines and Healthcare products Regulatory Agency (MHRA) Device Bulletins Date: 18 June 2010 Draft Accreditation Report for
More informationFinal Accreditation Report
Guidance producer: Medicines and Healthcare products Regulatory Agency (MHRA) Guidance product: Device Bulletins Date: 20 September 2010 Final Accreditation Report Page 1 of 21 Contents Introduction...
More informationMedicines and Healthcare products Regulatory Agency (MHRA) Guidance producer subject to accreditation. Process subject to accreditation
Guidance producer subject to accreditation Process subject to accreditation Medicines and Healthcare products Regulatory Agency (MHRA) Pharmacovigilance Public Assessment Reports Date: 18 June 2010 Draft
More informationMedicines and Healthcare products Regulatory Agency (MHRA) Public Assessment Reports
Guidance producer: Medicines and Healthcare products Regulatory Agency (MHRA) Guidance product: Public Assessment Reports Date: 18 June 2010 Version: 1.4 Draft Accreditation Report for consultation Medicines
More informationFinal Accreditation Report
Guidance producer: Royal College of Surgeons of England: Surgical Specialty Associations Guidance product: Clinical Commissioning Guides Date: 28 February 2013 Version: 1.3 Final Accreditation Report Royal
More informationEgton Medical Information Systems Limited (EMIS) Clinical Immediate Reference articles
Guidance producer: Egton Medical Information Systems Limited (EMIS) Guidance product: Clinical Immediate Reference articles Date: 17 August 2010 Final Accreditation Report Contents Introduction... 3 Accreditation
More informationFinal Accreditation Report
Guidance producer: Resuscitation Council (UK) Guidance product: 2010 resuscitation guidelines Date: 2 August 2012 Version: 1.4 Final Accreditation Report Page 1 of 19 Contents Introduction... 3 Accreditation
More informationFinal Accreditation Report
Guidance producer: Healthcare Infection Society Guidance product: Clinical Guidelines Date: 23 March 2015 Version: 1.6 Final Accreditation Report Page 1 of 19 Contents Introduction... 3 Accreditation recommendation...
More informationClinical guideline for the prevention and treatment of osteoporosis
Guidance producer: National Osteoporosis Guideline Group Guidance product: Clinical guideline for the prevention and treatment of osteoporosis Date: 9 March 2017 Version: 1.3 Final Accreditation Report
More informationThe Renal Association
Guidance producer: The Renal Association Guidance product: Clinical Practice Guidelines Date: 11 January 2017 Version: 1.4 Final Accreditation Report Contents Introduction... 3 Accreditation recommendation...
More informationDraft Accreditation Report for consultation
Guidance producer: Guidance product: NHS Fetal Anomaly Screening Programme (FASP) UK National Screening Committee (NSC) NHS Fetal Anomaly Screening Programme Screening for Down s syndrome: UK NSC Policy
More informationFinal Accreditation Report
Guidance producer: The Royal College of Physicians of London Guidance product: National Clinical Guideline for Stroke Date: 19 September 2016 Version: 1.2 Final Accreditation Report Report Page 1 of 21
More informationBritish Association of Dermatologists
Guidance producer: British Association of Dermatologists Guidance product: Service Guidance and Standards Date: 13 March 2017 Version: 1.2 Final Accreditation Report Page 1 of 26 Contents Introduction...
More informationFinal Accreditation Report - for guidance and advice for use in decision support systems
Guidance producer: NHS Direct Guidance product: The content of the Call Streaming Prioritisation Tool and Teleguides Date: 2 January 2013 Version: 1.4 Final Accreditation Report - for guidance and advice
More informationFinal Accreditation Report
Guidance producer: British National Formulary Publications Guidance product: Nurse Prescribers Formulary Date: 10 March 2014 Final Accreditation Report Page 1 of 28 Contents Introduction... 3 Accreditation
More informationAccreditation Decision Report for consultation
Guidance producer: British National Formulary Publications Guidance product: British National Formulary, British National Formulary for Children Date: 29 August 2013 Version: 1.4 Accreditation Decision
More informationBritish Society for Surgery of the Hand. (BSSH) Evidence for Surgical
British Society for Surgery of the Hand (BSSH) Evidence for Surgical Treatment (B.E.S.T.) Process Manual 1 st Edition (12 th version, November 2016) Review Date: November 2019 BSSH Evidence for Surgical
More informationDraft National Quality Assurance Criteria for Clinical Guidelines
Draft National Quality Assurance Criteria for Clinical Guidelines Consultation document July 2011 1 About the The is the independent Authority established to drive continuous improvement in Ireland s health
More informationCOMMISSIONING SUPPORT PROGRAMME. Standard operating procedure
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE COMMISSIONING SUPPORT PROGRAMME Standard operating procedure April 2018 1. Introduction The Commissioning Support Programme (CSP) at NICE supports the
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and Social Care Directorate Quality standards Process guide
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and Social Care Directorate Quality standards Process guide December 2014 Quality standards process guide Page 1 of 44 About this guide This guide
More informationDocument Details Clinical Audit Policy
Title Document Details Clinical Audit Policy Trust Ref No 1538-31104 Main points this document covers This policy details the responsibilities and processes associated with the Clinical Audit process within
More informationHow NICE clinical guidelines are developed
Issue date: January 2009 How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS Fourth edition : an overview for stakeholders, the public and the NHS Fourth edition
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Interim Process and Methods of the Highly Specialised Technologies Programme
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Principles Interim Process and Methods of the Highly Specialised Technologies Programme 1. Our guidance production processes are based on key principles,
More informationAre you responding as an individual or on behalf of an organisation?
Response form Address: 407 St John Street, London, EC1V 4AD Are you responding as an individual or on behalf of an organisation? If as an individual, are you responding as: a) a doctor? b) a patient? c)
More informationIssue date: October Guide to the multiple technology appraisal process
Issue date: October 2009 Guide to the multiple technology appraisal process Guide to the multiple technology appraisal process Issued: October 2009 This document is one of a series describing the processes
More informationClinical Practice Guideline Development Manual
Clinical Practice Guideline Development Manual Publication Date: September 2016 Review Date: September 2021 Table of Contents 1. Background... 3 2. NICE accreditation... 3 3. Patient Involvement... 3 4.
More informationProcess and methods Published: 23 January 2017 nice.org.uk/process/pmg31
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationNHS. The guideline development process: an overview for stakeholders, the public and the NHS. National Institute for Health and Clinical Excellence
NHS National Institute for Health and Clinical Excellence Issue date: April 2007 The guideline development process: an overview for stakeholders, the public and the NHS Third edition The guideline development
More informationUNIVERSITY OF BATH SABBATICAL LEAVE SCHEME Call for Applications
UNIVERSITY OF BATH SABBATICAL LEAVE SCHEME Call for Applications Sabbatical Leave Sabbatical leave is a period of release from normal academic duties in order to implement a programme of research activities.
More informationProcess and methods Published: 30 November 2012 nice.org.uk/process/pmg6
The guidelines manual Process and methods Published: 30 November 2012 nice.org.uk/process/pmg6 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationSupporting information for appraisal and revalidation: guidance for Occupational Medicine, April 2013
Supporting information for appraisal and revalidation: guidance for Occupational Medicine, April 2013 Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction
More informationMaximising the impact of nursing research. RCN research conference 5-7 April 2017, Oxford, UK
Maximising the impact of nursing research RCN research conference 5-7 April 2017, Oxford, UK Paper 1 Maximising the Impact of nursing research through collaboration Professor Daniel Kelly, RCN Professor
More informationInitial education and training of pharmacy technicians: draft evidence framework
Initial education and training of pharmacy technicians: draft evidence framework October 2017 About this document This document should be read alongside the standards for the initial education and training
More informationCLINICAL GOVERNANCE AND QUALITY COMMITTEE. Final - Terms of Reference - Final
CLINICAL GOVERNANCE AND QUALITY COMMITTEE Final - Terms of Reference - Final CONSTITUTION 1. The Board of Directors approved the establishment of the Clinical Governance and Quality Committee (known as
More informationSPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY
SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY 1 SUMMARY This document sets out Haringey Clinical Commissioning Group policy and advice to employees on sponsorship and joint working with
More informationNICE Charter Who we are and what we do
NICE Charter 2017 Who we are and what we do 1. The National Institute for Health and Care Excellence (NICE) is the independent organisation responsible for providing evidence-based guidance on health and
More informationSupporting information for appraisal and revalidation: guidance for Occupational Medicine, June 2014
Supporting information for appraisal and revalidation: guidance for Occupational Medicine, June 2014 Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction
More informationIndependent prescribing conversion programme. De Montfort University Report of a reaccreditation event May 2017
Independent prescribing conversion programme De Montfort University Report of a reaccreditation event May 2017 GPhC, independent prescribing conversion programme reaccreditation report Page 1 of 10 Event
More informationSupporting information for appraisal and revalidation: guidance for pharmaceutical medicine
Supporting information for appraisal and revalidation: guidance for pharmaceutical medicine Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction The purpose
More informationabcdefghijklmnopqrstu
Healthcare Policy and Strategy Directorate Quality Division Dear Colleague INTRODUCTION AND AVAILABILITY OF NEWLY LICENSED MEDICINES IN THE NHS IN SCOTLAND Dear Colleague This guidance sets out the policy
More informationIndependent Group Advising (NHS Digital) on the Release of Data (IGARD)
Document filename: Independent Group Advising (NHS Digital) on the Release of Data (IGARD) Directorate / Programme IGSA Project IGARD Document Reference Status Final Owner Martin Severs Version 1.6 Author
More informationWORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0
WORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0 1 Standard Operating Procedure St Helens CCG Working with The Pharmaceutical Industry Policy Version 1.0 Implementation Date May 2017 Review
More informationSupporting information for appraisal and revalidation: guidance for Supporting information for appraisal and revalidation: guidance for ophthalmology
FOREWORD As part of revalidation, doctors will need to collect and bring to their appraisal six types of supporting information to show how they are keeping up to date and fit to practise. The GMC has
More informationPOLICY ON THE IMPLEMENTATION OF NICE GUID ANCE
POLICY ON THE IMPLEMENTATION OF NICE GUID ANCE Document Type Corporate Policy Unique Identifier CO-019 Document Purpose To outline the process for the implementation and compliance with NICE guidance and
More informationJOB DESCRIPTION DIRECTOR OF SCREENING. Author: Dr Quentin Sandifer, Executive Director of Public Health Services and Medical Director
JOB DESCRIPTION DIRECTOR OF SCREENING Author: Dr Quentin Sandifer, Executive Director of Public Health Services and Medical Director Date: 1 November 2017 Version: 0d Purpose and Summary of Document: This
More informationNational Institute for Health and Clinical Excellence. The guidelines manual
National Institute for Health and Clinical Excellence The guidelines manual January 2009 The guidelines manual About this document This document describes the methods used in the development of NICE guidelines.
More informationMembership of Oral health for adults in care homes public health advisory committee
Committee membership list Oral health for adults in care homes guideline Committee Membership of Oral health for adults in care homes public health advisory committee The Committee will operate as an advisory
More informationGuidance on NHS Wales Patient Safety Solutions. December 2014
Guidance on NHS Wales Solutions December 2014 Digital ISBN 978-1-4734-2546-0 Crown copyright 2014 WG23419 Contents Background 1 Compliance 2 Appendix 1 Template and explanatory notes for a Alert 3 Appendix
More informationStandards for the provision of teleradiology within the United Kingdom Second edition. Standards
Standards for the provision of teleradiology within the United Kingdom Standards December 2016 Contents Foreword 3 1 Definition of teleradiology 4 2 Recommended standards 4 3 Introduction 5 4 Standards
More informationALLOCATION OF RESOURCES POLICY FOR CONTINUING HEALTHCARE FUNDED INDIVIDUALS
ALLOCATION OF RESOURCES POLICY FOR CONTINUING HEALTHCARE FUNDED INDIVIDUALS APPROVED BY: South Gloucestershire Clinical Commissioning Group Quality and Governance Committee DATE Date of Issue:- Version
More informationGUIDANCE ON SUPPORTING INFORMATION FOR REVALIDATION FOR SURGERY
ON SUPPORTING INFORMATION FOR REVALIDATION FOR SURGERY Based on the Academy of Medical Royal Colleges and Faculties Core Guidance for all doctors GENERAL INTRODUCTION JUNE 2012 The purpose of revalidation
More informationNational Reporting and Learning Service (NRLS) Data Quality Standards. Guidance for organisations reporting to the Reporting and Learning System (RLS)
National Reporting and Learning Service (NRLS) Data Quality Standards Guidance for organisations reporting to the Reporting and Learning System (RLS) September 2009 Introduction to the NRLS The are designed
More informationINCENTIVE SCHEMES & SERVICE LEVEL AGREEMENTS
MAY 2007 INCENTIVE SCHEMES & SERVICE LEVEL AGREEMENTS Practice Based Commissioning North and South Essex Local Medical Committees CLARIFYING THE RELATIONSHIP BETWEEN PBC GROUPS AND PCTS AIMS The aim of
More informationCORRESPONDING AUTHOR:
TITLE: A paediatrician s guide to Clinical Trials Units AUTHORS: Chris Gale, Edmund Juszczak CORRESPONDING AUTHOR: Dr C Gale, NIHR Clinical Trials Fellow, Imperial Clinical Trials Unit and section of Neonatal
More informationSupporting information for appraisal and revalidation: guidance for psychiatry
Supporting information for appraisal and revalidation: guidance for psychiatry Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction The purpose of revalidation
More informationQUALITY COMMITTEE. Terms of Reference
QUALITY COMMITTEE Terms of Reference CONSTITUTION 1. The Board of Directors approved the establishment of the Quality Committee (known as the Committee in these terms of reference) for the purpose of:
More informationCentral Alerting System (CAS) Policy
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray
More informationSalford Integrated Care System Governance Framework: Adult Health and Care Services FINAL
Salford Integrated Care System Governance Framework: Adult Health and Care Services FINAL 1 Background and Scope Salford is a forward thinking health and social care economy and as such has established
More informationTrust Board Meeting: Wednesday 12 March 2014 TB Peer Review Programme Implementation Update
Trust Board Meeting: Wednesday 12 March 2014 Title Peer Review Programme Implementation Update Status History For discussion Papers providing updates on the process and outcomes of the Peer Review Programme
More informationClinical Development Process 2017
InterQual Clinical Development Process 2017 InterQual Overview Thousands of people in hospitals, health plans, and government agencies use InterQual evidence-based clinical decision support content to
More informationStill Being NICE After 14 Years
Still Being NICE After 14 Years Dr Bhash Naidoo / Technical Adviser National Institute for Health and Care Excellence (NICE) Centre for Health Technology Evaluation London / United Kingdom bhash.naidoo@nice.org.uk
More informationNIHR COCHRANE COLLABORATION PROGRAMME GRANT SCHEME
NIHR COCHRANE COLLABORATION PROGRAMME GRANT SCHEME GUIDELINES FOR APPLICANTS The NIHR Cochrane Collaboration Programme Grant Scheme was established to provide high quality systematic reviews that will
More informationTrust Policy and Procedure Document Ref. No: PP (17) 283. Central Alerting System (CAS) Policy and Procedure. For use in: For use by: For use for:
Trust Policy and Procedure Document Ref. No: PP (17) 283 Central Alerting System (CAS) Policy and Procedure For use in: For use by: For use for: Document owner: Status: All areas of the Trust including
More information5.3: POLICY FOR THE MANAGEMENT OF REQUESTS FOR MEDICINES VIA PEER APPROVED CLINICAL SYSTEM (PACS) TIER 2
NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 5: NON-FORMULARY PROCESSES 5.3: POLICY FOR THE MANAGEMENT OF REQUESTS FOR MEDICINES VIA PEER APPROVED CLINICAL SYSTEM
More informationNOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST. PATIENT ACCESS MANAGEMENT POLICY (Previously known as Waiting List Management Policy) Documentation Control
NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST PATIENT ACCESS MANAGEMENT POLICY (Previously known as Waiting List Management Policy) Documentation Control Reference CL/CGP/026 Approving Body Senior Management
More informationEuropean Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications
European Reference Networks Guidance on the recognition of Healthcare Providers and UK Oversight of Applications NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients
More informationYorkhill Children s Charity Research Strategy
Yorkhill Children s Charity Research Strategy 1. Objectives Yorkhill Children s Charity provides and supports excellence in paediatric, obstetric and neonatal healthcare enhancing the treatment, care and
More informationCCG Policy for Working with the Pharmaceutical Industry
CCG Policy for Working with the Pharmaceutical Industry 1. Introduction Medicines are the most frequently and widely used NHS treatment and account for over 12% of NHS expenditure. The Pharmaceutical Industry
More informationADVANCED NURSE PRACTITIONER STRATEGY
ADVANCED NURSE PRACTITIONER STRATEGY 2016-2020 Lead Manager: Chair, GG&C Advanced Practice Group Responsible Director: Board Nurse Director Approved by: NMAHP Group Date approved Date for review: September
More informationINTRODUCTION TO THE UK PUBLIC HEALTH REGISTER ROUTE TO REGISTRATION FOR PUBLIC HEALTH PRACTITIONERS
INTRODUCTION TO THE UK PUBLIC HEALTH REGISTER ROUTE TO REGISTRATION FOR PUBLIC HEALTH PRACTITIONERS This introduction consists of: 1. Introduction to the UK Public Health Register 2. Process and Structures
More informationIndependent Mental Health Advocacy. Guidance for Commissioners
Independent Mental Health Advocacy Guidance for Commissioners DH INFORMATION READER BOX Policy HR / Workforce Management Planning / Performance Clinical Estates Commissioning IM&T Finance Social Care /
More informationabcdefghijklmnopqrstu
Directorate of Chief Medical Officer, Public Health and Sport abcdefghijklmnopqrstu T: 0131-244 2655 F: 0131-244 2285 E: craig.gilbert@scotland.gsi.gov.uk Dear Colleague ACCREDITATION SCHEME FOR THE COLLECTION
More informationMinor Surgery DES. Criteria for General Practitioners
Minor Surgery DES Criteria for General Practitioners In order to provide services under the Minor Surgery Directed Enhanced Service, a GP must be accredited or re-accredited to provide minor surgery at
More informationImplementation of the right to access services within maximum waiting times
Implementation of the right to access services within maximum waiting times Guidance for strategic health authorities, primary care trusts and providers DH INFORMATION READER BOX Policy HR / Workforce
More informationSection 2: Advanced level nursing practice competencies
Advanced Level Nursing Practice Section 2: Advanced level nursing practice competencies RCN Standards for advanced level nursing practice, advanced nurse practitioners, RCN accreditation and RCN credentialing
More informationReport of a Scoping Exercise for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO)
Continuity of Care Report of a Scoping Exercise for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO) Summer 2000 prepared by George Freeman and Sasha Shepperd
More informationQUALITY COMMITTEE. Terms of Reference
QUALITY COMMITTEE Terms of Reference This Committee will report to NHS Halton CCG Governing Body on the development, improvement and monitoring of all areas of quality. This will include clinical effectiveness,
More informationAGENDA ITEM 17b Annex (i)
QUALITY AND PATIENT SAFETY COMMITTEE Minutes of the meeting held on 10 th April 2014 Welsh Health Specialised Services Committee Offices Unit 3a, Van Road Caerphilly Business Park Caerphilly CF83 3ED Present
More informationMedicines Management Strategy
Medicines Management Strategy 2012 2014 Directorate responsible for the strategy: Medical and Governance Directorate Staff group to whom it applies: All clinical staff and Trust managers Issue date: 30/6/12
More informationGuideline scope Intermediate care - including reablement
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Intermediate care - including reablement Topic The Department of Health in England has asked NICE to produce a guideline on intermediate
More informationRapid Response Report NPSA/2009/RRR004: Preventing delay to follow up for patients with glaucoma
Rapid Response Report NPSA/2009/RRR004: Preventing delay to follow up for patients with glaucoma 11 June 2009 Supporting Information INDEX Page Introduction 2 Background 2 Scale of the patient safety issue
More informationNHSLA Risk Management Standards
NHSLA Risk Management Standards 2012-13 for NHS Trusts providing Acute Services Brighton and Sussex University Hospitals NHS Trust Level 1 October 2012 Contents Executive Summary... 3 Assessment Outcome...
More informationAPPROVAL UNDER SECTION 12(2) MENTAL HEALTH ACT 1983 THE NATIONAL CRITERIA FOR ENGLAND. Revised October 2009 by the National Reference Group
APPROVAL UNDER SECTION 12(2) MENTAL HEALTH ACT 1983 1. INTRODUCTION THE NATIONAL CRITERIA FOR ENGLAND Revised October 2009 by the National Reference Group 1.1 Section 12(2) of the Mental Health Act 1983
More informationUtilisation Management
Utilisation Management The Utilisation Management team has developed a reputation over a number of years as an authentic and clinically credible support team assisting providers and commissioners in generating
More informationEducation Adopting and adapting clinical guidelines for local use
Education 2007;9:48 52 10.1576/toag.9.1.048.27296 www.rcog.org.uk/togonline The Obstetrician & Gynaecologist Education Adopting and adapting clinical guidelines for local use Author Gillian C Penney Key
More informationThe PCT Guide to Applying the 10 High Impact Changes. A guide from NatPaCT
The PCT Guide to Applying the 10 High Impact Changes A guide from NatPaCT DH INFORMATION READER BOX Policy HR/Workforce Management Planning Clinical Estates Performance IM&T Finance Partnership Working
More informationWORKING WITH THE PHARMACEUTICAL INDUSTRY
WORKING WITH THE PHARMACEUTICAL INDUSTRY Page 1 of 11 WORKING WITH THE PHARMACEUTICAL INDUSTRY CCG Policy Reference: SuttonCCG/SLCSU/GOV/099 THIS POLICY WILL BE APPROVED BY THE CLINICAL COMMISSIONING GROUP
More informationUKRI Future Leaders Fellowships Frequently Asked Questions
UKRI Future Leaders Fellowships Frequently Asked Questions This document will be regularly updated to reflect those questions most frequently raised with UK Research and Innovation (UKRI). Potential applicants,
More informationCOMMISSIONING FOR QUALITY FRAMEWORK
This document is uncontrolled once printed. Please check on the CCG s Intranet site for the most up to date version COMMISSIONING FOR QUALITY FRAMEWORK Document Title: Commissioning for Quality Framework
More informationCLINICAL GOVERNANCE STRATEGY. For West Sussex PCT
CLINICAL GOVERNANCE STRATEGY For West Sussex PCT 2006 2009 Agreed by the Clinical Governance Committee: 31/01/07 Effective from: 31/01/07 Review: 31/07/07 Page 1 of 8 Contents Page Introduction 3 Principles
More informationQuality and Safety Committee Terms of Reference
Approved May 2016 Quality and Safety Committee Terms of Reference 1. Constitution The Quality and Safety Committee is established as a sub-committee of The Hillingdon Hospitals NHS Foundation Trust (THH)
More informationGuidance on implementing the principles of peer review
Guidance on implementing the principles of peer review MAY 2016 Principles of peer review Peer review is the best way for health and medical research charities to decide what research to fund. Done properly,
More information25 June 2018 Conference Programme
North West Stroke Conference 2018 25 June 2018 Conference Programme North West Stroke Conference 2018 Sponsored by Conference Chairs Dr Liz Lightbody Liz is a Reader in Health Services Research in the
More informationConsultation on initial education and training standards for pharmacy technicians. December 2016
Consultation on initial education and training standards for pharmacy technicians December 2016 The text of this document (but not the logo and branding) may be reproduced free of charge in any format
More informationSIGN 139 Care of deteriorating patients. Consensus recommendations May Evidence
SIGN 139 Care of deteriorating patients Consensus recommendations May 2014 Evidence Scottish Intercollegiate Guidelines Network Care of deteriorating patients Consensus recommendations May 2014 Care of
More informationMethods: National Clinical Policies
Methods: National Clinical Policies Choose an item. NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Commissioning
More informationDocument Title: GCP Training for Research Staff. Document Number: SOP 005
Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:
More informationSpeech and Language Therapy Competency Framework to Guide Transition to Certified RCSLT Membership. Newly Qualified Practitioners.
Speech and Language Therapy Competency Framework to Guide Transition to Certified RCSLT Membership Newly Qualified Practitioners June 2007 Speech and Language Therapy Competency Framework to Guide Transition
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Centre for Health Technology Evaluation
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Centre for Health Technology Evaluation Increasing capacity within Technology Appraisals Consultation comments proforma Name Role Organisation E-Mail Address
More informationSection Title. Prescribing competency framework Catherine Picton, Lead author
Prescribing competency framework Catherine Picton, Lead author What is in this presentation Context Uses of the competency framework Scope of the updated prescribing competency framework Introduction to
More information